174 related articles for article (PubMed ID: 38573338)
21. Hydrogen sulfide alleviates mitochondrial damage and ferroptosis by regulating OPA3-NFS1 axis in doxorubicin-induced cardiotoxicity.
Wang Y; Ying X; Wang Y; Zou Z; Yuan A; Xiao Z; Geng N; Qiao Z; Li W; Lu X; Pu J
Cell Signal; 2023 Jul; 107():110655. PubMed ID: 36924813
[TBL] [Abstract][Full Text] [Related]
22. Natural compound glycyrrhetinic acid protects against doxorubicin-induced cardiotoxicity by activating the Nrf2/HO-1 signaling pathway.
Cheng Y; Wu X; Nie X; Wu Y; Zhang C; Lee SM; Lv K; Leung GP; Fu C; Zhang J; Li J
Phytomedicine; 2022 Nov; 106():154407. PubMed ID: 36070662
[TBL] [Abstract][Full Text] [Related]
23. Dihydroartemisinin alleviates doxorubicin-induced cardiotoxicity and ferroptosis by activating Nrf2 and regulating autophagy.
Lin ZH; Xiang HQ; Yu YW; Xue YJ; Wu C; Lin C; Ji KT
FASEB J; 2024 May; 38(10):e23677. PubMed ID: 38775792
[TBL] [Abstract][Full Text] [Related]
24. Ethoxyquin is a Competent Radical-Trapping Antioxidant for Preventing Ferroptosis in Doxorubicin Cardiotoxicity.
Tadokoro T; Ikeda M; Abe K; Ide T; Miyamoto HD; Furusawa S; Ishimaru K; Watanabe M; Ishikita A; Matsushima S; Koumura T; Yamada KI; Imai H; Tsutsui H
J Cardiovasc Pharmacol; 2022 Nov; 80(5):690-699. PubMed ID: 35881422
[TBL] [Abstract][Full Text] [Related]
25. Loss of TRIM21 alleviates cardiotoxicity by suppressing ferroptosis induced by the chemotherapeutic agent doxorubicin.
Hou K; Shen J; Yan J; Zhai C; Zhang J; Pan JA; Zhang Y; Jiang Y; Wang Y; Lin RZ; Cong H; Gao S; Zong WX
EBioMedicine; 2021 Jul; 69():103456. PubMed ID: 34233258
[TBL] [Abstract][Full Text] [Related]
26. Human Amnion Membrane Proteins Prevent Doxorubicin-Induced Oxidative Stress Injury and Apoptosis in Rat H9c2 Cardiomyocytes.
Faridvand Y; Haddadi P; Vahedian V; Nozari S; Nejabati HR; Pezeshkian M; Afrasiabi A; Safaie N; Jodati A; Nouri M
Cardiovasc Toxicol; 2020 Aug; 20(4):370-379. PubMed ID: 32086724
[TBL] [Abstract][Full Text] [Related]
27. Lapatinib induces mitochondrial dysfunction to enhance oxidative stress and ferroptosis in doxorubicin-induced cardiomyocytes via inhibition of PI3K/AKT signaling pathway.
Sun L; Wang H; Xu D; Yu S; Zhang L; Li X
Bioengineered; 2022 Jan; 13(1):48-60. PubMed ID: 34898356
[TBL] [Abstract][Full Text] [Related]
28. Protective effects of dimethyl itaconate in mice acute cardiotoxicity induced by doxorubicin.
Shan Q; Li X; Zheng M; Lin X; Lu G; Su D; Lu X
Biochem Biophys Res Commun; 2019 Sep; 517(3):538-544. PubMed ID: 31376936
[TBL] [Abstract][Full Text] [Related]
29. Punicalagin protects H9c2 cardiomyocytes from doxorubicin-induced toxicity through activation of Nrf2/HO-1 signaling.
Ye M; Zhang L; Yan Y; Lin H
Biosci Rep; 2019 May; 39(5):. PubMed ID: 31015369
[TBL] [Abstract][Full Text] [Related]
30. Sulforaphane protects the heart from doxorubicin-induced toxicity.
Singh P; Sharma R; McElhanon K; Allen CD; Megyesi JK; Beneš H; Singh SP
Free Radic Biol Med; 2015 Sep; 86():90-101. PubMed ID: 26025579
[TBL] [Abstract][Full Text] [Related]
31. Cardamonin protects against doxorubicin-induced cardiotoxicity in mice by restraining oxidative stress and inflammation associated with Nrf2 signaling.
Qi W; Boliang W; Xiaoxi T; Guoqiang F; Jianbo X; Gang W
Biomed Pharmacother; 2020 Feb; 122():109547. PubMed ID: 31918264
[TBL] [Abstract][Full Text] [Related]
32. Insulin-like growth factor II receptor-α is a novel stress-inducible contributor to cardiac damage underpinning doxorubicin-induced oxidative stress and perturbed mitochondrial autophagy.
Pandey S; Kuo WW; Shen CY; Yeh YL; Ho TJ; Chen RJ; Chang RL; Pai PY; Viswanadha VP; Huang CY; Huang CY
Am J Physiol Cell Physiol; 2019 Aug; 317(2):C235-C243. PubMed ID: 31116582
[TBL] [Abstract][Full Text] [Related]
33. Licochalcone A alleviates ferroptosis in doxorubicin-induced cardiotoxicity via the PI3K/AKT/MDM2/p53 pathway.
Chen G; Luo S; Guo H; Lin J; Xu S
Naunyn Schmiedebergs Arch Pharmacol; 2024 Jun; 397(6):4247-4262. PubMed ID: 38078919
[TBL] [Abstract][Full Text] [Related]
34. FNDC5 alleviates oxidative stress and cardiomyocyte apoptosis in doxorubicin-induced cardiotoxicity via activating AKT.
Zhang X; Hu C; Kong CY; Song P; Wu HM; Xu SC; Yuan YP; Deng W; Ma ZG; Tang QZ
Cell Death Differ; 2020 Feb; 27(2):540-555. PubMed ID: 31209361
[TBL] [Abstract][Full Text] [Related]
35. Myocardial protection against pressure overload in mice lacking Bach1, a transcriptional repressor of heme oxygenase-1.
Mito S; Ozono R; Oshima T; Yano Y; Watari Y; Yamamoto Y; Brydun A; Igarashi K; Yoshizumi M
Hypertension; 2008 Jun; 51(6):1570-7. PubMed ID: 18426999
[TBL] [Abstract][Full Text] [Related]
36. MiR-15b-5p is Involved in Doxorubicin-Induced Cardiotoxicity via Inhibiting Bmpr1a Signal in H9c2 Cardiomyocyte.
Wan GX; Cheng L; Qin HL; Zhang YZ; Wang LY; Zhang YG
Cardiovasc Toxicol; 2019 Jun; 19(3):264-275. PubMed ID: 30535663
[TBL] [Abstract][Full Text] [Related]
37. Signalling mechanisms underlying doxorubicin and Nox2 NADPH oxidase-induced cardiomyopathy: involvement of mitofusin-2.
McLaughlin D; Zhao Y; O'Neill KM; Edgar KS; Dunne PD; Kearney AM; Grieve DJ; McDermott BJ
Br J Pharmacol; 2017 Nov; 174(21):3677-3695. PubMed ID: 28261787
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of METTL3 ameliorates doxorubicin-induced cardiotoxicity through suppression of TFRC-mediated ferroptosis.
Wu L; Du Y; Wang L; Zhang Y; Ren J
Redox Biol; 2024 Jun; 72():103157. PubMed ID: 38631119
[TBL] [Abstract][Full Text] [Related]
39. Bach1 regulates osteoclastogenesis in a mouse model via both heme oxygenase 1-dependent and heme oxygenase 1-independent pathways.
Hama M; Kirino Y; Takeno M; Takase K; Miyazaki T; Yoshimi R; Ueda A; Itoh-Nakadai A; Muto A; Igarashi K; Ishigatsubo Y
Arthritis Rheum; 2012 May; 64(5):1518-28. PubMed ID: 22127667
[TBL] [Abstract][Full Text] [Related]
40. Liposomal doxorubicin attenuates cardiotoxicity via induction of interferon-related DNA damage resistance.
Gyöngyösi M; Lukovic D; Zlabinger K; Spannbauer A; Gugerell A; Pavo N; Traxler D; Pils D; Maurer G; Jakab A; Riesenhuber M; Pircher A; Winkler J; Bergler-Klein J
Cardiovasc Res; 2020 Apr; 116(5):970-982. PubMed ID: 31346605
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]